Your browser doesn't support javascript.
loading
Structural insights into differences in G protein activation by family A and family B GPCRs.
Hilger, Daniel; Kumar, Kaavya Krishna; Hu, Hongli; Pedersen, Mie Fabricius; O'Brien, Evan S; Giehm, Lise; Jennings, Christine; Eskici, Gözde; Inoue, Asuka; Lerch, Michael; Mathiesen, Jesper Mosolff; Skiniotis, Georgios; Kobilka, Brian K.
Affiliation
  • Hilger D; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • Kumar KK; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • Hu H; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • Pedersen MF; Department of Structural Biology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • O'Brien ES; Zealand Pharma A/S, Sydmarken 11, Søborg 2860, Denmark.
  • Giehm L; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • Jennings C; Zealand Pharma A/S, Sydmarken 11, Søborg 2860, Denmark.
  • Eskici G; Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Inoue A; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • Lerch M; Department of Structural Biology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA.
  • Mathiesen JM; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan.
  • Skiniotis G; Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Kobilka BK; Zealand Pharma A/S, Sydmarken 11, Søborg 2860, Denmark. jmm@zealandpharma.com yiorgo@stanford.edu kobilka@stanford.edu.
Science ; 369(6503)2020 07 31.
Article de En | MEDLINE | ID: mdl-32732395
ABSTRACT
Family B heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) play important roles in carbohydrate metabolism. Recent structures of family B GPCR-Gs protein complexes reveal a disruption in the α-helix of transmembrane segment 6 (TM6) not observed in family A GPCRs. To investigate the functional impact of this structural difference, we compared the structure and function of the glucagon receptor (GCGR; family B) with the ß2 adrenergic receptor (ß2AR; family A). We determined the structure of the GCGR-Gs complex by means of cryo-electron microscopy at 3.1-angstrom resolution. This structure shows the distinct break in TM6. Guanosine triphosphate (GTP) turnover, guanosine diphosphate release, GTP binding, and G protein dissociation studies revealed much slower rates for G protein activation by the GCGR compared with the ß2AR. Fluorescence and double electron-electron resonance studies suggest that this difference is due to the inability of agonist alone to induce a detectable outward movement of the cytoplasmic end of TM6.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteurs au glucagon / Récepteurs bêta-2 adrénergiques / Sous-unités alpha Gs des protéines G Limites: Humans Langue: En Journal: Science Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteurs au glucagon / Récepteurs bêta-2 adrénergiques / Sous-unités alpha Gs des protéines G Limites: Humans Langue: En Journal: Science Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...